MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA
The search of molecular markers of metastasing and prognosis in prostate cancer remains an urgent task. In this study, we investigated the relationship of gene expression heparanase-1 (HPSE1) and D-glucuronil C5-epimerase (GLCE) with early disease relapse and metastasis of a 2,5−3 years after diagno...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/360 |
id |
doaj-02c80368eec24979b004ffc49725504f |
---|---|
record_format |
Article |
spelling |
doaj-02c80368eec24979b004ffc49725504f2021-07-29T08:41:40ZrusABV-pressOnkourologiâ 1726-97761996-18122014-08-0184485210.17650/1726-9776-2012-8-4-48-52375MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMAI. S. Kunin0M. M. Boboev1O. S. Kutsenko2L. A. Mostovich3S. V. Aidagulova4E. V. Grigorieva5Novosibirsk state medical universityNovosibirsk regional clinicsInstitute of molecular biology and biophysics, Siberian Division of RAMS, NovosibirskInstitute of molecular biology and biophysics, Siberian Division of RAMS, NovosibirskNovosibirsk state medical universityInstitute of molecular biology and biophysics, Siberian Division of RAMS, NovosibirskThe search of molecular markers of metastasing and prognosis in prostate cancer remains an urgent task. In this study, we investigated the relationship of gene expression heparanase-1 (HPSE1) and D-glucuronil C5-epimerase (GLCE) with early disease relapse and metastasis of a 2,5−3 years after diagnosis. It was shown that the ratio of the expression levels of genes HPSE1/GLCE > 1 may serve as a prognostic relapse marker and trends of the tumour to metastasis. The data obtained suggest to use this option as a molecular marker for the diagnostics of metastatic process and the disease prognosis.https://oncourology.abvpress.ru/oncur/article/view/360prostate adenocarcinomamolecular markers for prostate cancer metastasisheparanase-1d-glucuronyl c5-epimerase |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
I. S. Kunin M. M. Boboev O. S. Kutsenko L. A. Mostovich S. V. Aidagulova E. V. Grigorieva |
spellingShingle |
I. S. Kunin M. M. Boboev O. S. Kutsenko L. A. Mostovich S. V. Aidagulova E. V. Grigorieva MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA Onkourologiâ prostate adenocarcinoma molecular markers for prostate cancer metastasis heparanase-1 d-glucuronyl c5-epimerase |
author_facet |
I. S. Kunin M. M. Boboev O. S. Kutsenko L. A. Mostovich S. V. Aidagulova E. V. Grigorieva |
author_sort |
I. S. Kunin |
title |
MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA |
title_short |
MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA |
title_full |
MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA |
title_fullStr |
MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA |
title_full_unstemmed |
MOLECULAR MARKERS FOR METASTATIC PROSTATE ADENOCARCINOMA |
title_sort |
molecular markers for metastatic prostate adenocarcinoma |
publisher |
ABV-press |
series |
Onkourologiâ |
issn |
1726-9776 1996-1812 |
publishDate |
2014-08-01 |
description |
The search of molecular markers of metastasing and prognosis in prostate cancer remains an urgent task. In this study, we investigated the relationship of gene expression heparanase-1 (HPSE1) and D-glucuronil C5-epimerase (GLCE) with early disease relapse and metastasis of a 2,5−3 years after diagnosis. It was shown that the ratio of the expression levels of genes HPSE1/GLCE > 1 may serve as a prognostic relapse marker and trends of the tumour to metastasis. The data obtained suggest to use this option as a molecular marker for the diagnostics of metastatic process and the disease prognosis. |
topic |
prostate adenocarcinoma molecular markers for prostate cancer metastasis heparanase-1 d-glucuronyl c5-epimerase |
url |
https://oncourology.abvpress.ru/oncur/article/view/360 |
work_keys_str_mv |
AT iskunin molecularmarkersformetastaticprostateadenocarcinoma AT mmboboev molecularmarkersformetastaticprostateadenocarcinoma AT oskutsenko molecularmarkersformetastaticprostateadenocarcinoma AT lamostovich molecularmarkersformetastaticprostateadenocarcinoma AT svaidagulova molecularmarkersformetastaticprostateadenocarcinoma AT evgrigorieva molecularmarkersformetastaticprostateadenocarcinoma |
_version_ |
1721252534367027200 |